Article: Somaxon Pharmaceuticals, Inc. Initiates Phase III Clinical Trials of SILENOR in Patients with Insomnia; Product Will Be Evaluated in Adult and Elderly Patients with Primary Chronic Insomnia and Transient Insomnia.

Article: Somaxon Pharmaceuticals, Inc. Initiates Second Phase III Clinical Trial of SILENOR(TM) -- Product will be evaluated in long-term trial of elderly patients with primary chronic insomnia.
Business Wire;  September 20, 2005 ;     682 words ......begun in the second Phase III clinical trial...placebo-controlled Phase III clinical trial...Onset (WASO), the sleep maintenance endpoint recommended...SILENOR(TM) in this Phase III clinical trial...difficulty maintaining sleep, it is not a ...

Article: CMS Releases Stark Phase III Regulations.(United States. Centers for Medicare and Medicaid Services)
Mondaq Business Briefing;  September 4, 2007 ;     700+ words ......copy of the long-awaited Stark II Phase III Regulations. Overall, healthcare providers should be pleased with the Phase III Stark rules. Despite fears that...would be drastically altered, the Phase III revisions are for the most part...

Article: Phase III Medical Receives Investment of $750,000; Robert J. Aholt, Jr., Newly Appointed COO, Purchases Securities of Company.
Business Wire;  September 29, 2004 ;     597 words ...MELVILLE, N.Y. -- Phase III Medical, Inc. (OTCBB:PHSM), an innovative...confident about the future growth of Phase III. This investment demonstrates my commitment...Company quickly reach its potential. Phase III's innovative approach to the dynamic...

Article: Somaxon Pharmaceuticals Announces Positive Results in a Phase II Dose-Finding Study of Low-Dose Doxepin in Elderly Patients with Primary Sleep Maintenance Insomnia.
Business Wire;  April 21, 2005 ;     700+ words ......patients with primary sleep maintenance insomnia. Low-dose...in all secondary sleep maintenance endpoints as well...elderly patients with sleep maintenance insomnia. In January...adults with primary sleep maintenance insomnia. On the...preparing to enter Phase ...

Article: Stark II, Phase III: And Still More To Come!(United States. Centers for Medicare and Medicaid Services)(Medicare Catastrophic Coverage Repeal Act of 1989)
Mondaq Business Briefing;  September 27, 2007 ;     700+ words ......Patient Referrals Act, commonly known as Stark. This Phase III Final Rule (Phase III) was published on September 5, 2007 and will become...days later, on December 5, 2007. In publishing Phase III, CMS both responds to public comments on Phase...

Article: Phase III Medical Announces Appointment of Harvard's Dr. Wayne Marasco as Senior Scientific Advisor.
Business Wire;  November 23, 2004 ;     700+ words ...MELVILLE, N.Y. -- Phase III Medical, Inc. (OTCBB:PHSM), an innovative...Marasco joined the Board of Directors of Phase III Medical in June 2003. He is an Associate...biographical information on Dr. Marasco and Phase III Medical, please refer to the Company...

Article: Phase III Medical Launches New Web Site - www.phase3med.com.
Business Wire;  November 3, 2004 ;     593 words ...MELVILLE, N.Y. -- Phase III Medical, Inc. (OTCBB:PHSM), an innovative...Companies interested in obtaining Phase III's innovative funding and business...send their business plans directly to Phase III for review and evaluation. For shareholders...

Article: Endovasc Announces Plans to Bypass Phase II Liprostin Clinical Trials and Proceed to Phase III.
Business Wire;  May 7, 2001 ;     519 words ......announced plans to move directly into Phase III human trials with Critical Limb Ischemic...has determined it will proceed with Phase III, i.e., the last phase of IND clinical...amp; II clinical trials and proceed to Phase III, on the condition that the trial would...

Article: Phase III Medical Appoints Robin Smith, M.D., M.B.A. as Chairman of the Company's Advisory Board.
Business Wire;  September 21, 2005 ;     700+ words ...MELVILLE, N.Y. -- Phase III Medical, Inc. (OTCBB:PHSM), an innovative...insurance companies. Mark Weinreb, CEO of Phase III, stated, We are extremely pleased to have Dr. Smith serve as Chairman of the Phase III Advisory Board. We believe that her...

Article: Phase III Medical Hires Seasoned Business Strategist as Chief Operating Officer.
Business Wire;  September 15, 2004 ;     700+ words ......Financial Development and Business Analysis Phase III Medical (OTCBB:PHSM), an innovative business...California. Mark Weinreb, President and CEO of Phase III Medical, said, We're delighted to have Bob join the Phase III Medical team. Following more than a decade...

Article: Key Reviews For Compliance With Stark Law Phase III Regulations.(Centers for Medicare and Medicaid Services)
Mondaq Business Briefing;  September 26, 2007 ;     564 words ......third phase of its final rulemaking (Phase III) regarding the Stark Law. The regulations promulgated under Phase III will go into effect December 4, 2007...arrangements that should be reviewed under Phase III. Any arrangements with physician groups...

Article: Hemispherx Biopharma Completes Full Enrollment of its Phase III Clinical Trial for Chronic Fatigue Syndrome (CFS).
Business Wire;  December 9, 2002 ;     700+ words ......2002 First Ever Completely Enrolled Phase III Clinical Trial for Disorder Affecting...Fatigue Syndrome, announced today that its Phase III, pivotal study in Chronic Fatigue Syndrome...Development Milestone in CFS Therapy The phase III pivotal study is rigorous in design and...

Article: Axonyx Initiates Second Phase III Alzheimer's Disease Trial with Phenserine.
Business Wire;  June 16, 2004 ;     700+ words ......announced the initiation of its second Phase III international clinical trial with its...Netherlands signals the formal start of this Phase III clinical trial and patient recruitment...clinical development program and this second Phase III trial will be conducted at multiple ...

Article: ALEXION REPORTS PHASE III RESULTS FOR PRIMO-CABG2 TRIAL.
Biotech Business;  January 1, 2006 ;     647 words ......Conn., has reported results from its Phase III PRIMO-CABG2 clinical trial with pexelizumab...complement-mediated tissue damage. The Phase III trial titled Pexelizumab for Reduction...PRIMO-CABG2 on its second international pivotal phase III study of pexelizumab, the APEX-AMI trial...